The impact of anxiety and depression on relapse in patients with inflammatory bowel disease;El papel de la ansiedad y la depresión en las recidivas de la enfermedad inflamatoria intestinal

Medicina Clinica

Volumn 132, Issue 8, 2009, Pages 298-302

  Vidal, Ángela ^a   Gómez Gil, Esther ^a   Sans, Miquel ^a   Portella, María J ^b   Salamero, Manel ^a   Piqué, Josep M ^a   Panés, Julián ^a  

^a HOSPITAL CLÍNIC   (Spain)

^b HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

Author keywords

Anxiety; Depression; Inflammatory bowel Disease; Relapse

Indexed keywords

ADULT; ANXIETY DISORDER; ARTICLE; CLINICAL EVALUATION; COLITIS; CONTROLLED STUDY; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; ENTERITIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; RECURRENT DISEASE; REMISSION; RISK FACTOR; SEMI STRUCTURED INTERVIEW;

ADULT; ANXIETY; CROHN DISEASE; DEPRESSION; FEMALE; HUMANS; MALE; PROSPECTIVE STUDIES; RECURRENCE;

EID: 60949091267     PISSN: 00257753     EISSN: 15788989     Source Type: Journal    
DOI: 10.1016/j.medcli.2008.07.002     Document Type: Article

References (31)

1. Prakash A., and Marakham A. Oral delayed-release mesalazine: a review of its use in ulcerative colitis and Crohn's disease. Drugs. 57 (1999) 383-408
2. Bitton A., Sewitch M.J., Peppecorn M.A., Edwardes M.D., Shah S., Ransil B., et al. Psychosocial determinants of relapse in ulcerative colitis: a longitudinal study. Am J Gastroenterol. 98 (2003) 2203-2208
3. Levenstein S., Prantera C., Varvo V., Scribano M.L., Andreoli A., Luzi C., et al. Stress and exacerbation in ulcerative colitis: a prospective study of patients enrolled in remission. Am J Gastroenterol. 95 (2000) 1213-1221
4. North C.S., Alpers D., Helzer J., Spitznagel E.L., and Clouse R.E. Do life events or depression exacerbate inflammatory bowel disease?. Ann Intern Med. 114 (1991) 381-386
5. Li J., Norgard B., Precht D.H., and Olsen J. Psychological stress and inflammatory bowel disease: a follow-up study in parents who lost a child in Denmark. Am J Gastroenterol. 99 (2004) 1129-1133
6. Vidal A., Gómez E., Sans M., Portella M.J., Salamero M., Piqué J.M., et al. Life events and inflammatory bowel disease relpase: a prospective study of patients enrolled in remission. Am J Gastroenterol. 101 (2006) 775-781
7. Garrett V., Brantley P., Jones G., and Mcknight G.T. The relation between daily stress and Crohn's disease. J Behav Med. 14 (1991) 87-95
8. Greene B.R., Blanchard E.B., and Wan C.K. Long term monitoring of psychosocial stress and symptomatology in inflammatory bowel disease. Behav Res Ther. 32 (1994) 217-226
9. Levenstein S., Prantera C., Varvo V., Scriban M.L., Berto E., Andreoli A., et al. Psychological stress and disease activity in ulcerative colitis: a multidimensional cross-sectional study. Am J Gastroenterol. 89 (1994) 1219-1225
10. Riley S.A., Masni V., Goodman M.J., and Lucas S. Why do patients with ulcerative colitis relapse?. Gut. 31 (1990) 179-183
11. Mardini H.E., Kip K.E., and Wilson J.W. Crohn's disease: a two-year prospective study of the association between psychological distress and disease activity. Dig Dis Sci. 49 (2004) 492-497
12. Mittermaier C., Clemens D., Waldhoer T., Oefferlbauer-Ernst A., Miehlser W., Beier M., et al. Impact of depressive mood in relapse in patients with inflammatory bowel disease: a prospective 18-month follow-up study. Psychosom Med. 66 (2004) 79-84
13. Lustman P.J., Griffith L.S., and Freedland K.E. The course of major depression in diabetes. Int J Psychiatry Med. 12 (1982) 67-73
14. Fifield J., Tennen H., and Reisine S. Depression and the long-term risk of pain, fatigue, and disability in patients with rheumatoid arthritis. Arthritis Rheum. 41 (1998) 1851-1857
15. Carney R.M., Rich M.W., and Freedland K.E. Major depressive disorder predicts cardiac events in patients with coronary artery disease. Psychosom Med. 50 (1988) 627-633
16. Gómez E., Vidal A., Panés J., Jaén J., Fernández E., and Piqué J.M. Asociación entre acontecimientos vitales estresantes de la vida e inicio o actividad de la enfermedad inflamatoria intestinal según la percepción subjetiva del paciente. Gastroenterol Hepatol. 6 (2003) 411-416
17. Vidal A., Gómez E., and Peri J. Aspectos psicológicos y psiquiátricos en las enfermedades inflamatorias intestinales. Rev Psiquiatría Fac Med Barna. 30 (2003) 97-104
18. Lennard-Jones J.E. Classification of inflammatory bowel disease. Scand J Gastroenterol Suppl. 24 (1989) 2-6
19. Van Hees P.A., Van Elteren P.H., Van Lier H.J., and Van Tongeren J.H. An index of inflammatory activity in patients with Crohn's disease. Gut. 21 (1980) 289-296
20. Truelove S.C., and Witts L.J. Cortisone in ulcerative colitis: final report on a therapeutic trial. Br Med J. 2 (1955) 1041-1049
21. American Psychiatric Association. Manual diagnóstico y estadístico de los trastornos mentales: DSM-IV (1995), Masson, Barcelona
22. Harvey R.F., and Bradshaw J.M. A simple index of Crohn's disease activity. Lancet. 1 (1980) 514
23. Walmsley R.S., Ayres R.C.S., Pounder R.E., and Allan R.N. A simple clinical colitis activity index. Gut. 43 (1998) 29-32
24. Evans J.M., McMahon A.D., Murray F.E., McDevitt D.G., and MacDonald T.M. Non-steroidal anti-inflammatory drugs are associated with emergency admission to hospital for colitis due to inflammatory bowel disease. Gut. 40 (1997) 619-622
25. Corrao G., Tragnone A., Caprilli R., Trallori G., Papi C., Andreoli A., et al. Risk of inflammatory bowel disease attributable to smoking, oral contraception and breastffeding in Italy: a nationwide case-control study. Cooperative Investigators Group for the Study of the Colon and the Rectum (GISC). Int J Epidemiol. 27 (1998) 397-404
26. Fraser A.G., Orchard T.R., and Jewell D.P. The efficacy of azathioprine for the treatment of inflammatory bowel disease: a 30 years review. Gut 50 (2002) 485-489
27. Bitton A., Peppecorn M.A., and Antioneli D.A. Course of ulcerative colitis: analysis of changes in disease activity over years. Gastroenterol. 120 (2001) 13-20
28. Andrews H., Barczak P., and Allan R. Psychiatric illness in patients with inflammatory bowel disease. Gut. 28 (1987) 1600-1604
29. Persoons P., Vermeiere S., Demyttenaere K., Fischler B., and Vandeberghe J. The impact of major depressive disorder on the short-and long-term utcome of Crohn's disease treatment with infliximab. Aliment Pharmacol Ther. 22 (2005) 101-110
30. Drossman D.A., Leserman J., Mitchell M., Li Z., Zagami E.A., and Patrick D.L. Health status and health care use in persons with inflammatory bowel disease. A national sample. Dig Dis Sci. 36 (1991) 1746-1755
31. Vidal A., Gómez E., Sans M., Portella M.J., Salamero M., Piqué J.M., et al. Health-related quality of life in inflammatory bowel disease patients: the role of psychopathology and personality». Inflamm Bowel Dis. 14 (2008) 977-983